Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Accelerometry Reveals Differences in Gait Variability Between Patients with Multiple Sclerosis and Healthy Controls.
Environment may play significant role in multiple sclerosis.
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Human Aquaporin 4281-300 Is the Immunodominant Linear Determinant in the Context of HLA-DRB1*03:01: Relevance for Diagnosing and Monitoring Patients With Neuromyelitis OpticaImmunodominant Linear Determinants of hAQP4.
[Interferon-β1b in multiple sclerosis therapy : More than 20 years clinical experience.]
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Overall Memory Impairment Identification with Mathematical Modeling of the CVLT-II Learning Curve in Multiple Sclerosis.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
Fulminant demyelinating diseases.
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.
Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells.
Color-Code Agreement Among Stratus, Cirrus, and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis With and Without Prior Optic Neuritis.
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
A bird's-eye view of T cells during natalizumab therapy.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
T-cell trafficking in the central nervous system.
Remyelination: The True Regeneration of the Central Nervous System.
Pages
« first
‹ previous
…
199
200
201
202
203
204
205
206
207
…
next ›
last »